Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02332785 · ClinicalTrials.gov registry record

Prospective Study of Colon Serrated Polyps

A clinical trial of Colon Polyps, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT02332785 is a study of Colon Polyps that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 10,000 participants, above the 112-participant average among 5 other Colon Polyps trials with a reported enrollment target (8829% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02332785, a study of Colon Polyps, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

With this study, the investigators plan to review the clinical, epidemiology, pathology, and endoscopic features of colon serrated lesions as well as outcome of endoscopic resection of these lesions. The findings will help us define the natural history of colon serrated lesions, develop techniques for endoscopic management of patients with serrated lesions, and identity areas for improvement. The data will be used for continuing quality improvement and presenting our outcomes at academic meetings and publishing our results in peer reviewed journals.

Conditions Studied

Interventions

  • OTHER Data Collection

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2014-11
Est. Completion 2027-11

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT02332785

The ClinicalTrials.gov registry entry for NCT02332785 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 112-participant average among 5 other Colon Polyps trials with a reported enrollment target (8829% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colon Polyps appearing as the primary indexed condition, and to 1 intervention - of which Data Collection is the first listed.

NCT02332785 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02332785 about?

NCT02332785 is a clinical study titled "Prospective Study of Colon Serrated Polyps". With this study, the investigators plan to review the clinical, epidemiology, pathology, and endoscopic features of colon serrated lesions as well as outcome of endoscopic resection of these lesions. The findings will help us define the natural history of colon serrated lesions, develop techniques f...

What is the current status of trial NCT02332785?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2014-11. Estimated completion is 2027-11.

What conditions does trial NCT02332785 study?

This clinical trial studies the following conditions: Colon Polyps.

What interventions are being tested in trial NCT02332785?

The interventions under investigation include: Data Collection (OTHER).

Who is sponsoring clinical trial NCT02332785?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02332785 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colon Polyps

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.